COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
Status:
Completed
Trial end date:
2007-12-28
Target enrollment:
Participant gender:
Summary
This study was designed to determine whether treatment with COREG MR is more effective at
maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.